Related content

Fascaplysin, a selective CDK4 inhibitor, exhibit anti-angiogenic activity in vitro and in vivo

By Lin Jing   Yan Xiao-Jun   Chen Hai-Min  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 4, 2007-03 ,pp. : 439-445

Springer Publishing Company

Access to resources Recommend Favorite

Dickkopf Wnt signaling pathway inhibitor 1 regulates the differentiation of mouse embryonic stem cells in vitro and in vivo

By            

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 720-730

Spandidos Publications

Access to resources Recommend Favorite

Effect of novel CAAX peptidomimetic farnesyltransferase inhibitor on angiogenesis in vitro and in vivo - targeting simply Ras?

By Gu W.-Z.   Tahir S.K.   Wang Y.-C.   Zhang H.-C.   Cherian S.P.   O'Connor S.   Leal J.A.   Rosenberg S.H.   Ng S.-C.  

European Journal of Cancer, Vol. 35, Iss. 9, 1999-09 ,pp. : 1394-1401

Elsevier

Access to resources Recommend Favorite

Antitumor effect of the selective COX-2 inhibitor celecoxib on endometrial adenocarcinoma in vitro and in vivo

By        

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1219-1224

Spandidos Publications

Access to resources Recommend Favorite

Antitumor effect of the mTOR inhibitor everolimus in combination with trastuzumab on human breast cancer stem cells in vitro and in vivo

By Zhu Yuanxi  

Tumor Biology, Vol. 33, Iss. 5, 2012-10 ,pp. : 1349-1362

Springer Publishing Company

Access to resources Recommend Favorite